Latest Weight Loss news
Oral GLP-1 Receptor Agonist Orforglipron Beneficial for Adults With Obesity, T2DM
posted December 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy
posted November 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Trump Announces Major Price Cut for Ozempic, Wegovy and Similar Drugs
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use 
2021 to 2026 Saw Increase in State Funding for Suicide Prevention 
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets 
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss Related Articles
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
Weight Cycling Linked to Increased Loss of Muscle Volume 
Compounded GLP-1 Receptor Agonists Remain Widely Available 
Review Shows Most Obesity Drugs Do Not Aid Quality of Life, Heart Health Monthly Specialist Briefings
Stay Connected
